Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
0.232
-0.129 (-35.77%)
At close: Mar 6, 2026, 4:00 PM EST
0.230
-0.002 (-0.95%)
After-hours: Mar 6, 2026, 7:57 PM EST
Lunai Bioworks Market Cap
Lunai Bioworks has a market cap or net worth of $5.62 million as of March 6, 2026. Its market cap has decreased by -95.82% in one year.
Market Cap
5.62M
Enterprise Value
7.88M
1-Year Change
-95.82%
Ranking
Category
Stock Price
$0.23
Market Cap Chart
Since December 11, 2018, Lunai Bioworks's market cap has decreased from $252.00M to $5.62M, a decrease of -97.77%. That is a compound annual growth rate of -40.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.60M | -72.95% |
| Dec 31, 2025 | 20.70M | -84.39% |
| Dec 31, 2024 | 132.60M | -37.28% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 6.39M |
| Can-Fite BioPharma | 6.38M |
| Aprea Therapeutics | 6.30M |
| Purple Biotech | 6.02M |
| Aspire Biopharma Holdings | 5.83M |
| Psyence Biomedical | 5.76M |
| Quince Therapeutics | 5.70M |
| Silexion Therapeutics | 5.41M |